Consensus minimum hemoglobin level above which patients with myelodysplastic syndromes can safely forgo transfusions

Abstract The anemia of MDS often results in decreased quality of life, which is invoked to justify red cell transfusions; however, there are sparse data regarding the minimum hemoglobin (Hb) at which it is safe to forgo transfusions for patients with no evidence of end-organ damage. This issue is even more important in the COVID-19 era, where decreases in blood donations have stressed the blood supply. In March 2018, using a modified Delphi method, we convened a panel of 13 expert MDS clinicians for three iterative rounds to discuss a minimum safe Hb for this population. While the panel was unable to reach the pre-set consensus of 75% for a specific Hb threshold, there was 100% consensus that it be no greater than 7.5 g/dL. Our data suggest that, given no end-organ effects of anemia, patients with MDS can safely forgo transfusions with a Hb of 7.5 g/dL or higher.

[1]  P. Meybohm,et al.  Patient blood management during the COVID–19 pandemic: a narrative review , 2020, Anaesthesia.

[2]  C. Zenger,et al.  Essential Role of Patient Blood Management in a Pandemic: A Call for Action , 2020, Anesthesia and analgesia.

[3]  E. Staley,et al.  Prepare to adapt: blood supply and transfusion support during the first 2 weeks of the 2019 novel coronavirus (COVID‐19) pandemic affecting Washington State , 2020, Transfusion.

[4]  E. Wood,et al.  Red cell transfusion in outpatients with myelodysplastic syndromes: a feasibility and exploratory randomised trial , 2020, British journal of haematology.

[5]  J. Bishop,et al.  Consensus Clinical Decision-Making Factors Driving Anticoagulation in Atrial Fibrillation. , 2019, The American journal of cardiology.

[6]  Patients as experts: characterizing the most relevant patient-reported outcomes after hematopoietic cell transplantation , 2019, Bone Marrow Transplantation.

[7]  P. Yates,et al.  Harnessing the power of clinician judgement. Identifying risk of deteriorating and dying in people with a haematological malignancy: A Delphi study , 2018, Journal of advanced nursing.

[8]  M. Franchini,et al.  Red blood cell transfusion policy: a critical literature review. , 2017, Blood transfusion = Trasfusione del sangue.

[9]  Eva van der Meij,et al.  A modified Delphi method toward multidisciplinary consensus on functional convalescence recommendations after abdominal surgery , 2016, Surgical Endoscopy.

[10]  I. Koutsavlis.  Transfusion Thresholds, Quality of Life, and Current Approaches in Myelodysplastic Syndromes , 2016, Anemia.

[11]  T. Grogan,et al.  Testing an Adapted Modified Delphi Method , 2016, Health promotion practice.

[12]  P. Vyas,et al.  Comparison of a restrictive versus liberal red cell transfusion policy for patients with myelodysplasia, aplastic anaemia, and other congenital bone marrow failure disorders. , 2015, The Cochrane database of systematic reviews.

[13]  B. Chaitman,et al.  Liberal or restrictive transfusion in high-risk patients after hip surgery. , 2011, The New England journal of medicine.

[14]  J. Vincent,et al.  Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. , 2010, JAMA.

[15]  M. Cazzola,et al.  Predicting survival and leukemic evolution in patients with myelodysplastic syndrome. , 2006, Haematologica.

[16]  N. Roubinian,et al.  Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. , 2016, The Cochrane database of systematic reviews.

[17]  B. Burnand,et al.  The RAND/UCLA Appropriateness Method User's Manual , 2001 .

[18]  G. Wells,et al.  A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. , 1999, The New England journal of medicine.

[19]  D. Hunter,et al.  Qualitative Research: Consensus methods for medical and health services research , 1995 .

[20]  K. Kahn,et al.  Physician ratings of appropriate indications for six medical and surgical procedures. , 1986, American journal of public health.